Brian Baranick, General Mgr, Precision Oncology at EXACT SCIENCES CORP (EXAS), sold 4,054 shares at $56.89 ($231K) on 2024-02-27, disclosed to the SEC on 2024-02-28.
Scheduled sale ($231k) by General Mgr, Precision Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.89 | 2,027 | $115K | 50.0% |
| 2 | $56.89 | 2,027 | $115K | 50.0% |
| Total | $56.89 avg | 4,054 | $231K | 100% |
| Filing → |
| EXAS | SELL | 2024-09-19 | $65K | — | Filing → |
| EXAS | SELL | 2024-05-02 | $7K | — | Filing → |
| EXAS | SELL | 2024-04-03 | $147K | — | Filing → |